Notes
British pounds
Reference
Becker U, et al. Cost-Effectiveness Model for Chemoimmunotherapy Options in Patients with Previously Untreated Chronic Lymphocytic Leukemia Unsuitable for Full-Dose Fludarabine-Based Therapy. Value in Health 19: 374-82, No. 4, Jun 2016. Available from: URL: http://doi.org/10.1016/j.jval.2015.12.018
Rights and permissions
About this article
Cite this article
Obinutuzumab plus chlorambucil cost effective in untreated CLL. PharmacoEcon Outcomes News 756, 26 (2016). https://doi.org/10.1007/s40274-016-3175-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3175-1